225 related articles for article (PubMed ID: 34586537)
21. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.
Overman MJ; Soifer HS; Schueneman AJ; Ensor J; Adsay V; Saka B; Neishaboori N; Wolff RA; Wang H; Schnabel CA; Varadhachary G
BMC Cancer; 2016 Aug; 16(1):668. PubMed ID: 27549176
[TBL] [Abstract][Full Text] [Related]
22. Ampullary cancer: an overview.
Ahn DH; Bekaii-Saab T
Am Soc Clin Oncol Educ Book; 2014; ():112-5. PubMed ID: 24857067
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients.
Baghmar S; Agrawal N; Kumar G; Bihari C; Patidar Y; Kumar S; Chattopadhyay TK; Panda D; Arora A; Pamecha V
J Gastrointest Cancer; 2019 Sep; 50(3):361-369. PubMed ID: 29464529
[TBL] [Abstract][Full Text] [Related]
24. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
[TBL] [Abstract][Full Text] [Related]
25. Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater.
Hoffman JP; Cooper HS; Young NA; Pendurthi TK
J Hepatobiliary Pancreat Surg; 1998; 5(3):251-4. PubMed ID: 9880771
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of ampullary neoplasms in resected margin positive or uncertain cases after endoscopic papillectomy.
Sakai A; Tsujimae M; Masuda A; Iemoto T; Ashina S; Yamakawa K; Tanaka T; Tanaka S; Yamada Y; Nakano R; Sato Y; Kurosawa M; Ikegawa T; Fujigaki S; Kobayashi T; Shiomi H; Arisaka Y; Itoh T; Kodama Y
World J Gastroenterol; 2019 Mar; 25(11):1387-1397. PubMed ID: 30918431
[TBL] [Abstract][Full Text] [Related]
27. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
Overman MJ; Varadhachary GR; Kopetz S; Adinin R; Lin E; Morris JS; Eng C; Abbruzzese JL; Wolff RA
J Clin Oncol; 2009 Jun; 27(16):2598-603. PubMed ID: 19164203
[TBL] [Abstract][Full Text] [Related]
30. Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.
Kim HS; Shin SJ; Kim JH; Kim H; Choi HJ
Tohoku J Exp Med; 2013 Sep; 231(1):21-8. PubMed ID: 23994910
[TBL] [Abstract][Full Text] [Related]
31. Multimodal treatment of neuroendocrine tumors of the pancreas and the ampulla of Vater.
Mantke R; Manger T; Schulz HU; Ridwelski K; Pross M; Günther T; Lippert H
Dig Surg; 1999; 16(2):145-51. PubMed ID: 10207242
[TBL] [Abstract][Full Text] [Related]
32. Mutational profiling and immunohistochemical analysis of a surgical series of ampullary carcinomas.
Harthimmer MR; Stolborg U; Pfeiffer P; Mortensen MB; Fristrup C; Detlefsen S
J Clin Pathol; 2019 Nov; 72(11):762-770. PubMed ID: 31256008
[TBL] [Abstract][Full Text] [Related]
33. Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.
Erdmann JI; Morak MJ; Duivenvoorden HJ; van Dekken H; Kazemier G; Kok NF; van Eijck CH
HPB (Oxford); 2015 Jul; 17(7):573-9. PubMed ID: 25800041
[TBL] [Abstract][Full Text] [Related]
34. The Diagnosis and Treatment of Ampullary Carcinoma.
Walter D; Schnitzbauer AA; Schulze F; Trojan J
Dtsch Arztebl Int; 2023 Oct; 120(43):729-735. PubMed ID: 37656482
[TBL] [Abstract][Full Text] [Related]
35. Ampullary adenocarcinoma: Defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I disease.
Stiles ZE; Behrman SW; Deneve JL; Glazer ES; Dong L; Wan JY; Martin MG; Dickson PV
J Surg Oncol; 2018 Jun; 117(7):1500-1508. PubMed ID: 29518820
[TBL] [Abstract][Full Text] [Related]
36. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.
Shaib WL; Sharma R; Brutcher E; Kim S; Maithel SK; Chen Z; Kooby DA; Kauh J; Landry J; El-Rayes BF
J Surg Oncol; 2014 May; 109(6):556-60. PubMed ID: 24338561
[TBL] [Abstract][Full Text] [Related]
37. Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report.
Mauri G; Gori V; Patelli G; Roazzi L; Rizzetto F; De Carlis L; Mariani A; Cavallari U; Prada E; Cipani T; Aquilano MC; Bonoldi E; Vanzulli A; Siena S; Sartore-Bianchi A
World J Surg Oncol; 2023 Mar; 21(1):118. PubMed ID: 36998040
[TBL] [Abstract][Full Text] [Related]
38. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
[TBL] [Abstract][Full Text] [Related]
39. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
40. Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma.
Cheng J; Mao Y; Hong W; Hu W; Shu P; Huang K; Yu J; Jiang M; Li L; Wang W; Ni D; Li S
J Transl Med; 2022 Jun; 20(1):272. PubMed ID: 35705951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]